Nvidia and a Japanese industrial consortium are building what Nvidia calls the world’s first national AI infrastructure for physical AI, and the specification is unusually concrete for an announcement of this kind. The AI factory will run 13,750 Nvidia…
Microsoft executives spent an internal meeting on Tuesday teaching the sales force how to run down OpenAI, Google, and Anthropic, which would be unremarkable except that two of those companies supply the models inside Microsoft’s own products. The sess…
Forget Google Translate, this AI tool invents languages nobody has ever spoken, sounds, grammar, and all.
Reelful is an AI app that builds finished reels from your photos and clips, complete with voiceovers, captions, and music.
OpenAI has trained an elite hacker, then locked it in a cage. Its whole job is to break OpenAI’s own AI. The company says it is too dangerous to let anyone else near it. The model is called GPT-Red, and OpenAI detailed it this week. It is an automated …
For years, musicians have said AI song generators fed on their work without asking. A hacker just opened the black box and showed them exactly how. Leaked source code from Suno, one of the biggest AI music tools, tells the story. It trained its model b…
Apple built a trillion-dollar business on chips it designs itself. It cannot design the ones its AI needs fast enough, so it is going shopping. The iPhone maker is hunting for AI chip acquisitions, The Information reported. In recent months it has talk…
Boston Dynamics is testing Spot, its four-legged robot, as a delivery worker that rides along in trucks and hops out to carry packages to customers’ doorsteps. The company posted a video on Tuesday showing a human driver loading packages onto a conveyo…
Walden Robotics has launched from stealth with $300m and a $1.1bn valuation. The Toyota spin-out builds humanoids for factories, and it left off the legs on purpose. “If you listen to the people on the factory floor, they aren’t ready, and they don’t w…
No name. No product. No confirmed funding. And, possibly, a $2bn price tag. That is the shape of the newest bet in AI drug discovery. Miles Wang, a researcher at OpenAI, is leaving to start his own company, TechCrunch reported. He is in talks to raise …